Matthias H. Busch

ORCID: 0000-0001-7324-2471
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Vasculitis and related conditions
  • Long-Term Effects of COVID-19
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Renal Diseases and Glomerulopathies
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Complement system in diseases
  • Systemic Sclerosis and Related Diseases
  • Ion channel regulation and function
  • Sarcoidosis and Beryllium Toxicity Research
  • Peripheral Neuropathies and Disorders
  • Cardiac electrophysiology and arrhythmias
  • Immunodeficiency and Autoimmune Disorders
  • Blood Coagulation and Thrombosis Mechanisms
  • Cell Adhesion Molecules Research
  • T-cell and B-cell Immunology
  • Psoriasis: Treatment and Pathogenesis
  • Cardiomyopathy and Myosin Studies
  • S100 Proteins and Annexins
  • Respiratory Support and Mechanisms
  • Reproductive tract infections research
  • Linguistics, Language Diversity, and Identity

Maastricht University
2012-2024

Geneeskundige en Gezondheidsdienst
2024

Friedrich Schiller University Jena
2024

Maastricht University Medical Centre
2020-2023

ChemoCentryx (United States)
2023

Cardiovascular Institute Hospital
2022

Laurentius Ziekenhuis
2022

Saxon State Ministry for Science and the Arts
2019

Heidelberg University
2016

University Medical Center
2016

Alexander P. J. Vlaar Martin Witzenrath Pieter van Paassen Leo Heunks Bruno Mourvillier and 95 more Sanne de Bruin Endry H. T. Lim Matthijs C. Brouwer Pieter R. Tuinman José Francisco Kerr Saraiva Gernot Marx Suzana M. Lobo Rodrigo Boldo Jesus Abraham Simón Campos Alexander D. Cornet Anastasia Grebenyuk Johannes M. Engelbrecht Murimisi Mukansi Philippe G. Jorens Robert Zerbib Simon Rückinger Korinna Pilz Renfeng Guo Diederik van de Beek Niels C. Riedemann Alexander P. J. Vlaar Martin Witzenrath Pieter van Paassen Leo Heunks Bruno Mourvillier Sanne de Bruin Endry H. T. Lim Matthijs C. Brouwer Pieter R. Tuinman José Francisco Kerr Saraiva Gernot Marx Suzana M. Lobo Rodrigo Boldo Jesus Simon-Campos Alexander D. Cornet Anastasia Grebenyuk Johannes Engelbrecht Murimisi Mukansi Philippe G. Jorens Robert Zerbib Simon Rückinger Korinna Pilz Renfeng Guo Diederik van de Beek Niels C. Riedemann Pierre Bulpa Fabio Silvio Taccone Greet Hermans Marc Diltoer Michaël Piagnerelli Nikolaas De Neve Antonio Freire Felipe Dal‐Pizzol Anna Karolina Marinho Victor H. Sato Clóvis Arns da Cunha Mathilde Neuville Jean Dellamonica Djillali Annane Antoine Roquilly Jean Luc Diehl Francis Schneider Jean Paul Mira Jean Baptiste Lascarrou Luc Desmedt Claire Dupuis Carole Schwebel Guillaume Thiéry Matthias Gründling Marc Moritz Berger Tobias Welte Michael Bauer Ulrich Jaschinski Klaus Matschke Roberto Mercado-Longoría Belinda Gomez Quintana Jorge Alberto Zamudio-Lerma Juan Moreno Hoyos Abril Angel Aleman Marquez Peter Pickkers Luuk C. Otterspoor Luis Hercilla Vásquez Carlos Rafael Seas Ramos Alejandro Peña Villalobos Gonzalo Gianella Malca Victoria Chávez Victor Filimonov В. В. Кулабухов Pinak Acharya Sjoerd A.M.E.G. Timmermans Matthias H. Busch Floor L. F. van Baarle Rutger Koning Liora ter Horst Nora Chekrouni

10.1016/s2213-2600(22)00297-1 article EN The Lancet Respiratory Medicine 2022-09-07
Frank B. Cortazar John L. Niles David Jayne Peter A. Merkel Annette Bruchfeld and 95 more Huibin Yue Thomas J. Schall Pirow Bekker Chen Au Peh Aron Chakera Bruce A. Cooper Jadadeesh Kurtkoti Daman Langguth Vicki Levidiotis G. Luxton Peter F. Mount David W. Mudge Euan Noble R. Phoon Dwarakanathan Ranganathan A. Ritchie Jessica Ryan M. Suranyi Alexander R. Rosenkranz K. Lhotta Andreas Kronbichler Nathalie Demoulin C. Bovy R. Hellemans Jean‐Michel Hougardy Ben Sprangers Katherine D. Wissing Christian Pagnoux S. Barbour Soumeya Brachemi S. Cournoyer Louis Girard Louis‐Philippe Laurin Patrick Liang David Philibert Michael Walsh Vladimı́r Tesař Radim Bečvář P. Horak Ivan Rychlík Wladimir Szpirt Hans Dieperink Jon Waarst Gregersen Per Ivarsen Elizabeth Krarup Cecilie Lyngsoe Claire Rigothier Jean‐François Augusto Alexandre Bélot Dominique Chauveau Divi Cornec Noémie Jourde‐Chiche M. Ficheux Alexandre Karras Armelle Klein F. Maurier Rafik Mesbah Olivier Moranne A. Néel T. Quéméneur David Saadoun Benjamin Terrier Philippe Zaoui Matthias Schaier Urs Benck Raoul Bergner Matthias H. Busch Jürgen Floege Franziska Grundmann Hermann Haller Marion Haubitz B. Hellmich Jörg Henes Bernd Hohenstein C. Hugo Christof Iking‐Konert Fabian Arndt Torsten Kubacki Ina Kötter Peter Lamprecht Tom H. Lindner Jan Halbritter H. Mehling Ulf Schönermarck Nils Venhoff Volker Vielhauer Oliver Witzke István Szombati G Szücs Giacomo Garibotto Federico Alberici Enrico Brunetta Lorenzo Dagna Salvatore De Vita Giacomo Emmi

In the 330-patient ADVOCATE trial of avacopan for treatment antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis, in which 81% patients had renal involvement, estimated glomerular filtration rate (eGFR) increased on average 7.3 ml/min per 1.73 m2 group and 4.1 prednisone (P = 0.029) at week 52. This new analysis examines results patient subgroup with severe insufficiency enrollment into trial, i.e., eGFR ≤20 m2.eGFR was determined baseline over course trial. Changes were...

10.1016/j.ekir.2023.01.039 article EN cc-by-nc-nd Kidney International Reports 2023-02-03

• Prevalence of ESBL/pAmpC-producing E. coli is highest in chicken meat. Characteristics isolates from turkey meat are significantly different to those chicken. CTX-M group among the ESBL/pAmpC producing was (26.0%) and (24.0 %). Minced beef or pork contaminated at higher frequency than pork. Vegetables only a very low level Germany. The spread extended-spectrum β-lactamases (ESBLs) Escherichia major public health issue ESBL-producing bacteria frequently reported livestock. For assessment...

10.1016/j.vetmic.2019.03.025 article EN cc-by-nc-nd Veterinary Microbiology 2019-04-07
Laura Boekel Eileen W Stalman Luuk Wieske Femke Hooijberg Koos P J van Dam and 82 more Yaëlle R Besten Laura Kummer Maurice Steenhuis Zoé L. E. van Kempen Joep Killestein Adriaan Volkers Sander W. Tas Anneke J. van der Kooi Joost Raaphorst Mark Löwenberg R. Bart Takkenberg Geert R. DʼHaens Phyllis I. Spuls Marcel W. Bekkenk Annelie H. Musters Nicoline F. Post Angela L. Bosma Marc Hilhorst Yosta Vegting Fréderike J. Bemelman Alexandre E. Voskuyl Bo Broens Agner Parra Sanchez Cécile A. C. M. van Jelle de Wit Abraham Rutgers Karina de Leeuw Barbara Horváth Jan J.G.M. Verschuuren Annabel M. Ruiter Lotte van Ouwerkerk Diane van der Woude Cornelia F Allaart Y.K. Onno Teng Pieter van Paassen Matthias H. Busch Papay B P Jallah Esther Brusse Pieter A. van Doorn Adája E. Baars DirkJan Hijnen Corine R G Schreurs W. Ludo van der Pol H. Stephan Goedee Erik Vogelzang Maureen Leeuw Sadaf Atiqi Ronald van Vollenhoven Martijn Gerritsen Irene van der Horst‐Bruinsma Willem F. Lems Michael T. Nurmohamed Maarten Boers Sofie Keijzer Jim Keijser Carolien E. van de Sandt Arend Boogaard Olvi Cristianawati Anja ten Brinke Niels J. M. Verstegen Koos Zwinderman S. Marieke van Ham Theo Rispens Taco W. Kuijpers Gertjan Wolbink Filip Eftimov Rivka de Jongh Carolien E. van de Sandt Lisan H. Kuijper Mariël C Duurland Ruth R Hagen Jet van den Dijssel Christine Kreher Amélie Bos Viriginia Palomares Cabeza Veronique A. L. Konijn George Elias Juán A. Vallejo Marrit van Gils Tom Ashhurst Sergey Nejentsev Elham Sadat Mirfazeli

10.1016/s2665-9913(22)00102-3 article EN The Lancet Rheumatology 2022-04-29

Recently, we reported the phase II portion of adaptive II/III PANAMO trial exploring potential benefit and safety selectively blocking C5a with monoclonal antibody vilobelimab (IFX-1) in patients severe coronavirus disease 2019 (COVID-19). The potent anaphylatoxin attracts neutrophils monocytes to infection site, causes tissue damage by oxidative radical formation enzyme releases, leads activation coagulation system. Results demonstrated that inhibition was safe secondary outcomes appeared...

10.1111/cts.13213 article EN cc-by-nc Clinical and Translational Science 2022-01-14

Objectives To compare the cumulative incidence and disease severity of reported SARS-CoV-2 omicron breakthrough infections between patients with immune-mediated inflammatory diseases (IMID) on immunosuppressants controls, to investigate determinants for infections. Methods Data were used from an ongoing national prospective multicentre cohort study vaccination responses in IMID Netherlands (Target-to-B! (T2B!) study). Patients wih controls (patients not healthy controls) who completed...

10.1136/ard-2022-222904 article EN Annals of the Rheumatic Diseases 2022-09-05

SARS-CoV-2-specific CD8

10.1016/j.jaut.2024.103175 article EN cc-by-nc Journal of Autoimmunity 2024-02-21

Abstract During the COVID‐19 pandemic, daily life of many patients with dermatological immune‐mediated inflammatory diseases (DIMIDs), such as atopic dermatitis (AD), psoriasis, and vitiligo, was impacted by social restrictions caused (fear of) morbidity, mortality associated COVID‐19, vaccine hesitancy. This prospective observational, multicenter, multidisciplinary cohort study explored impact disease vaccination on DIMIDs, specifically AD, vitiligo. Data from DIMIDs were collected part...

10.1111/1346-8138.17664 article EN cc-by The Journal of Dermatology 2025-02-14

Abstract The risk of a venous thrombotic event (VTE) is increased in patients with antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV); however, detailed understanding the underlying mechanisms hypercoagulability limited. We assessed prospectively different coagulation parameters 71 active AAV at baseline and after 6 months follow-up. D-dimers fibrinogen were most presentation remained elevated half patients. Particularly, thrombin-antithrombin (T:AT) complex activated...

10.1182/bloodadvances.2023011937 article EN cc-by-nc-nd Blood Advances 2024-01-04

ANCA-associated GN is a common cause of rapidly progressive GN, with high relapse rates. The early recognition an importance to prevent loss kidney function. Urinary soluble CD163 has been identified as promising marker active GN. Previous studies, however, are limited by the lack histologic data.We analyzed urinary in 95 patients vasculitis who underwent biopsy. In total, 125 tissue sections (first biopsy, n=67; repeated n=58) concurrent 24-hour urine samples were studied. Correlation...

10.2215/cjn.07210520 article EN Clinical Journal of the American Society of Nephrology 2020-11-17

Neutrophil extracellular traps (NET) have been implicated in the pathogenesis of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Here, we developed a novel, label-free, high-throughput bio-impedance technique to effectively measure serum NET-inducing activity. Using this technique, activity derived from patients with AAV was assessed prospective cohort 62 presenting active major organ involvement. Thirty-five presented new and 27 relapsing AAV, whom 38 had kidney...

10.1016/j.kint.2023.03.029 article EN cc-by Kidney International 2023-04-23

Abstract Calcium signalling plays a critical role in the pathogenesis of heart failure. Here we describe cardiac protein named Myoscape/FAM40B/STRIP2, which directly interacts with L-type calcium channel. Knockdown Myoscape cardiomyocytes decreases transients associated smaller Ca 2+ amplitudes and lower diastolic content. Likewise, channel currents are significantly diminished on ablation, downregulation reduces contractility cardiomyocytes. Conversely, overexpression increases global...

10.1038/ncomms11317 article EN cc-by Nature Communications 2016-04-28

Objective. To evaluate in patients with AS (i) the fluctuation self-reported disease activity (BASDAI), patient global well-being [visual analogue scale (VAS)–global] and spinal pain (VAS-pain) during 2 years of follow-up on a group level (ii) clinical relevance these fluctuations level. Methods. Dutch from Outcome International Study cohort completed patient-reported outcome measures every months over years. On level, mixed linear models were used to analyse whether constant time. relevant...

10.1093/rheumatology/kew303 article EN Lara D. Veeken 2016-08-12

Abstract Background Patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressants (ISPs) may have impaired long-term humoral immune responses and increased disease activity after SARS-CoV-2 infection. We aimed to investigate against a primary infection in unvaccinated IMID patients ISPs. Methods active treatment ISPs controls (i.e. not ISP healthy controls) confirmed before first vaccination were included from an ongoing prospective cohort study (T2B! study). Clinical...

10.1186/s12879-023-08298-6 article EN cc-by BMC Infectious Diseases 2023-05-17

The aim of this study was to investigate further the role chlamydiae as pathogens in genital tracts sows at slaughter. Genital 101 randomly selected were collected and specimens tract localizations systematically examined for using immunohistochemistry PCR. In 10 sows, Chlamydia psittaci DNA detected by PCR, typed 'serotype 1' nine cases avian strain 6 BC one animal. However, all negative chlamydiae. Pooled samples scalding tank water additionally investigated 95 animals. Of these samples,...

10.1046/j.1439-0450.2000.00415.x article EN Journal of Veterinary Medicine Series B 2000-07-01

Leukocyte chemotaxis is deemed instrumental in initiation and progression of atherosclerosis. It mediated by G-protein-coupled receptors (e.g., CCR2 CCR5), the activity which controlled receptor kinases (GRKs). In this study, we analyzed effect hematopoietic deficiency a potent regulator kinase (GRK2) on atherogenesis. LDL receptor-deficient (LDLr–/–) mice with heterozygous GRK2 deficiency, generated bone marrow transplantation (n=15), displayed dramatic attenuation plaque development, 79%...

10.1096/fj.12-205351 article EN The FASEB Journal 2012-10-09

Ever since the global administration of various severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in response to disease 2019 (COVID-19), temporal associations between glomerulopathies and vaccination have been reported.1Li N.L. Coates P.T. Rovin B.H. COVID-19 followed by activation glomerular diseases: does association equal causation?.Kidney Int. 2021; 100: 959-965https://doi.org/10.1016/j.kint.2021.09.002Abstract Full Text PDF PubMed Scopus (20) Google Scholar Minimal...

10.1016/j.ekir.2021.12.023 article EN cc-by Kidney International Reports 2021-12-24
Endry H. T. Lim Alexander P. J. Vlaar Sanne de Bruin Simon Rückinger Claus Thielert and 84 more Maria Habel Renfeng Guo Bruce Burnett James Dickinson Matthijs C. Brouwer Niels C. Riedemann Diederik van de Beek Martin Witzenrath Pieter van Paassen Leo Heunks Bruno Mourvillier Matthijs C. Brouwer Pieter R. Tuinman José Francisco Kerr Saraiva Gernot Marx Suzana Margareth Lobo Rodrigo Boldo Jesus Abraham Simón Campos Alexander D. Cornet Anastasia Grebenyuk Johannes M. Engelbrecht Murimisi Mukansi Philippe G. Jorens Robert Zerbib Korinna Pilz Niels C. Riedemann Pierre Bulpa Fabio Silvio Taccone Greet Hermans Marc Diltoer Michaël Piagnerelli Nikolaas De Neve Antonio Freire Felipe Dal‐Pizzol Anna Karolina Marinho Victor H. Sato Clóvis Arns da Cunha Mathilde Neuville Jean Dellamonica Djillali Annane Antoine Roquilly Jean Luc Diehl Francis Schneider Jean Paul Mira Jean Baptiste Lascarrou Luc Desmedt Claire Dupuis Carole Schwebel Guillaume Thiéry Matthias Gründling Marc Moritz Berger Tobias Welte Michael Bauer Ulrich Jaschinski Klaus Matschke Roberto Mercado-Longoría Belinda Gomez Quintana Jorge Alberto Zamudio-Lerma Juan Moreno Hoyos Abril Angel Aleman Marquez Peter Pickkers Luuk C. Otterspoor Luis Hercilla Vásquez Carlos Rafael Seas Ramos Alejandro Peña Villalobos Gonzalo Gianella Malca Victoria Chávez Victor Filimonov В. В. Кулабухов Pinak Acharya Sjoerd A.M.E.G. Timmermans Matthias H. Busch Floor L. F. van Baarle Rutger Koning Liora ter Horst Nora Chekrouni Thijs M. van Soest Marleen A. Slim Lonneke A. van Vught Rombout B. E. van Amstel Sabine E. Olie Ingeborg E. van Zeggeren Marcel C.G. van de Poll Dorothee Neukirchen

Vilobelimab, a complement 5a (C5a)-specific monoclonal antibody, reduced mortality in critically ill COVID-19 patients phase 3 multicentre, randomized, double-blind, placebo-controlled study. As part of the study, vilobelimab concentrations and C5a levels as well antidrug antibodies (ADAs) to were analysed.From Oct 1, 2020 4, 2021, 368 invasively mechanically ventilated randomized: 177 randomly assigned receive while 191 received placebo. Pharmacokinetic sampling was only performed at sites...

10.1186/s40635-023-00520-8 article EN cc-by Intensive Care Medicine Experimental 2023-06-18

Rituximab (RTX) and cyclophosphamide (CYC) are effective remission-induction therapies in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). However, combining these may favor prognosis patients with a major disease presentation. We conducted retrospective study to compare treated combination of RTX low dose CYC (RTX-CYC) or only, both followed by tailored maintenance RTX, regard long-term outcomes.Patients the Maastricht University Medical Center between March 2007...

10.1016/j.jtauto.2022.100178 article EN cc-by Journal of Translational Autoimmunity 2022-12-15
Coming Soon ...